Empyema Necessitans Management
Initial Medical Management
- The American College of Physicians recommends starting broad-spectrum intravenous antibiotics immediately, targeting common pathogens, then adjusting based on culture results 1
- Antibiotic therapy should be continued for an extended duration, typically 2-4 weeks minimum, depending on clinical response 2
Diagnostic Workup
- Chest imaging, including radiography and CT with IV contrast, should be obtained to define the extent of pleural disease, chest wall involvement, and thickness of any pleural peel 3
- Aggressively pursuing cultures from pleural fluid and any accessible collections is crucial to guide antimicrobial therapy 2
Surgical Management Algorithm
- For early/uncomplicated cases, a small-bore chest drain should be inserted under ultrasound guidance, connected to a unidirectional drainage system 1
- Intrapleural urokinase should be administered twice daily for 3 days to facilitate drainage 1
- For advanced/organized cases, formal thoracotomy with decortication may be required for organized empyema with thick fibrous peel causing chronic sepsis, fever, and restricted lung expansion 3, 4
Critical Surgical Timing
- Early discussion with a thoracic surgeon is necessary if the patient fails to respond to chest tube drainage, antibiotics, and fibrinolytics within 48-72 hours 1
- Specific indications for surgical intervention include persisting sepsis, organized empyema with thick pleural peel, and multiloculated empyema not responding to medical management 3, 1
Important Caveats
- Surgical drainage of any coexisting lung abscess is not recommended, as empyema management and antibiotics will treat the lung abscess, and surgical drainage increases morbidity without improving outcomes 3, 4, 2
Supportive Care
- Antipyretics should be provided for fever control, and adequate analgesia, particularly with chest drains in place 4, 5, 1
- Chest physiotherapy should not be performed, as it provides no benefit in empyema 4, 5, 1
- Early mobilization and exercise should be encouraged once clinically stable 4, 5, 1
- Monitoring for secondary thrombocytosis is necessary, although it is common and benign, and requires no specific treatment 5, 1